Skip to main content

Table 2 Number of new vessels created after injection of MNC pre-incubated in sera from ILD patients, healthy volunteers, and PBS.

From: Angiogenic activity of sera from interstitial lung disease patients in relation to pulmonary function

 

No. of vessels

P vs. PBS

EAA

17.5 ± 1.3

0.001

WG

16.9 ± 1.4

0.001

CVD

16.6 ± 1.6

0.001

Sarcoidosis

16.3 ± 1.6

0.001

IPF

16.2 ± 0.9

0.001

Silicosis

15.7 ± 0.2

0.001

COP

15.4 ± 1.0

0.001

DIPF

13.2 ± 1.4

0.01

PBS

12.0 ± 1.2

-

PLH

10.8 ± 0.5

0.001

SCL

10.4 ± 0.7

0.001

Healthy volunteers

13.7 ± 0.9

0.001

  1. Number of vessels is given as means ± SD. EAA - extrinsic allergic alveolitis, WG - Wegener's granulomatosis, CVD - collagen vascular diseases, IPF - idiopathic pulmonary fibrosis, COP - cryptogenic organizing pneumonia, DIPF - drug-induced pulmonary fibrosis, PLH - pulmonary Langerhans cells histiocytosis, SCL - scleroderma.